You are here: Industry Insights > IPO

News List

Graphite Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares firstwordpharma
July 01, 2021
Graphite Bio, Inc. today announced the closing of its previously announced initial public offering of 14,000,000 shares of its common stock at a price to the public of $17.00 per share on June 29, 2021.
Cancer biotech Candel Therapeutics files for a $100 million IPO firstwordpharma
June 28, 2021
Candel Therapeutics filed with the US Securities and Exchange Commission to raise up to $100 million, Renaissance Capital reported.
Tatva Chintan Pharma Chem files for Rs 450-crore IPO expresspharma
April 06, 2021
Specialty chemical manufacturing company Tatva Chintan Pharma Chem has filed preliminary papers with Sebi to raise Rs 450 crore through an initial share sale.
BridgeBio Stock Up 60% So Far In Dec., IPO Lockup Period Expires Today firstwordpharma
December 25, 2019
Shares of BridgeBio Pharma have gone up 60% so far in December, as the clinical-stage biopharmaceutical company focused on developing medicines for genetic diseases gears up for some important events in the months ahead, reported Markets Insider.
Health catalyst announces pricing of IPO biospectrumasia
July 28, 2019
Health Catalyst has also granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock at the initial public offering
Frontage Holdings Completes IPO contractpharma
June 10, 2019
Proceeds from the global offering will be used to further expand the company's product development services capacity and capabilities.
Bicycle hires clinical leader ahead of IPO-fueled pipeline push fiercebiotech
May 10, 2019
Bicycle Therapeutics has hired clinical and program management leaders to support development of its anticancer candidates. The hires provide Bicycle with clinical trial expertise at a time when it is contending with the resignation of its chief medical o
Alector kicks off biotech IPOs after US government shutdown pharmaphorum
February 14, 2019
The 35-day US government shutdown has not just played havoc at government-run agencies – it has had a knock-on effect on the stock market because of cutbacks at the Securities and Exchange Commission financial regulator.
Anti-aging startup Juvenescence bags $46M for pipeline push fiercebiotech
January 17, 2019
Juvenescence has raised the first $46 million (€40 million) tranche of series B financing en route to an anticipated $100 million round.....
Harpoon files $86M IPO to help fund its T-cell engager platform fiercebiotech
January 04, 2019
Fresh off raising $70 million through a series C round just over a month ago, Harpoon Therapeutics announced it will go public with an $86.25 million IPO to further support its portfolio of early-stage T-cell engagers aimed at solid tumors.....

Previous page 1 2 3 4 5 6 7 8 9 Next page